OSMT News and Press, Osmotica Pharmaceuticals plc From 12/20/21

BRIDGEWATER, N.J., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a specialty pharmaceutical company, announced today that Brian Markison, Chief Executive Officer, James “JD” Schaub, Chie...

Having closed on the sale of its legacy business, Osmotica had UPNEEQ, arbaclofen ER, and little else. Despite having downsized, Osmotica is still incurring significant and growing ongoing expenses. Running UPNEEQ as a standalone business is challenging and may be doomed to failur...

Osmotica Pharmaceuticals plc (OSMT) Q3 2021 Earnings Conference Call November 15, 2021, 04:30 PM ET Company Participants Lisa Wilson - IR Brian Markison - CEO Andrew Einhorn - CFO JD Schaub - COO Conference Call Participants David Steinberg - Jefferies Greg Fraser - Truist Securities Presenta...

Osmotica Pharmaceuticals (NASDAQ:OSMT): Q3 GAAP EPS of -$0.28 beats by $0.04. Revenue of $2.19M (-96.2% Y/Y) misses by $0.17M. Press Release For further details see: Osmotica Pharmaceuticals EPS beats by $0.04, misses on revenue

Third quarter Upneeq® product sales of $2.2 million, representing 47% growth over second quarter sales Expansion of Upneeq launch continues with introduction of Direct Dispense program in eyecare and formation of Aesthetics business unit Sale of legacy business and ...

BRIDGEWATER, N.J., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a specialty pharmaceutical company, announced today that Brian Markison, Chief Executive Officer, James “JD” Schaub, Chie...

BRIDGEWATER, N.J., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a specialty pharmaceutical company, today announced that the Company will release its 2021 third quarter financial results on Monday, N...

BRIDGEWATER, N.J., Oct. 13, 2021 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a specialty pharmaceutical company, today announced that on October 12, 2021, it closed its previously announced underwritten public of...

A day of gains on Wall Street helped investors forget some of their recent worries on Thursday. This applied to much-maligned (and much-sold) China-based tech stocks, as Alibaba (NYSE:BABA) led a rally in the sector. Baidu (NASDAQ:BIDU), DiDi (NYSE:DIDI) and NetEase (NASDAQ:NTES) also posted ...

Gainers: Camber Energy (NYSE:CEI) +97%. Merus (NASDAQ:MRUS) +32%. New Fortress Energy (NASDAQ:NFE) +25%. Paltalk (NASDAQ:PALT) +25%. Grom Social Enterprises (NASDAQ:GROM) +20%. DatChat (NASDAQ:DATS) +20%. Jupiter Wellness (NASDAQ:JUPW) +18%. NextPlay Technologies (NASDAQ:NXTP) +19%. Independe...